Literature DB >> 11247886

Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.

P Rutgeerts1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11247886      PMCID： PMC1728253          DOI： 10.1136/gut.48.4.452

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

Authors:  H Lochs; M Mayer; W E Fleig; P B Mortensen; P Bauer; D Genser; W Petritsch; M Raithel; R Hoffmann; V Gross; M Plauth; M Staun; L B Nesje
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

2.  Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.

Authors:  C Cammà; M Giunta; M Rosselli; M Cottone
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682
  2 in total
  2 in total

1.  Clinical and endoscopic recurrence after surgical resection in patients with Crohn's disease.

Authors:  Yang Woon Lee; Kang-Moon Lee; Woo Chul Chung; Chang Nyol Paik; Hea Jung Sung; You Suk Oh
Journal:  Intest Res       Date:  2014-04-29

2.  Predictors of postoperative recurrence in a cohort of Tunisian patients with Crohn's disease.

Authors:  Aya Hammami; Raida Harbi; Nour Elleuch; Khaled Ben Meddeb; Wafa Ben Ameur; Wafa Dahmani; Ahlem Braham; Salem Ajmi; Mehdi Ksiaa; Aida Ben Slama; Hanen Jaziri; Ali Jmaa
Journal:  Ther Adv Gastrointest Endosc       Date:  2022-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.